RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Arcadia Biosciences Stock

Arcadia Biosciences Market capitalization 2024

Arcadia Biosciences Market capitalization

7.69 M USD

Ticker

RKDA

ISIN

US0390142042

WKN

A2JSFW

In 2024, Arcadia Biosciences's market cap stood at 7.69 M USD, a 122.74% increase from the 3.45 M USD market cap in the previous year.

The Arcadia Biosciences Market capitalization history

YEARMarket Capitalization (undefined USD)
20237.13
202221.27
202151.63
202036.64
201932.58
201831.86
201723.21
2016100.4
2015237.34
2014-
2013-
2012-

Arcadia Biosciences Aktienanalyse

What does Arcadia Biosciences do?

Arcadia Biosciences, Inc. is a California-based company specializing in agricultural biotechnology. The company was founded in 2002 with the goal of improving and making agriculture more sustainable. Arcadia Biosciences focuses on developing plants that are more resistant to external influences such as drought or diseases, resulting in higher yields. In 2003, Arcadia Biosciences entered into a partnership with Monsanto, one of the world's largest producers of pesticides and seeds. This partnership aimed to advance the development of plants that require less pesticides and water, enabling more sustainable agricultural production. In 2008, Arcadia Biosciences acquired seed producer IPFRI, increasing production capacity and accelerating the development of new plant varieties. In 2014, the company went public on the NASDAQ stock exchange under the ticker symbol RKDA. Since then, Arcadia Biosciences has formed additional partnerships and expanded its product range. The company's core business involves developing plant varieties that are resistant to diseases and environmental influences. Arcadia Biosciences utilizes a combination of genetic and conventional breeding methods to modify the genetic makeup of plants, enhancing or weakening certain traits. This approach allows for the development of plants that are less susceptible to pests or heat. As a partner to farmers and food manufacturers, Arcadia Biosciences also provides consulting and training to promote more sustainable agricultural production. Arcadia Biosciences is divided into three business segments: 1. Arcadia Specialty Genomics: This segment specializes in the development of plants with specific traits, such as higher nutrient content or enhanced resistance to diseases. 2. GoodWheat: Under this brand, Arcadia Biosciences sells wheat products that offer a healthier alternative to conventional wheat products due to their ingredients, such as higher fiber or protein content. 3. Hemp: This segment focuses on the development of hemp products, including oil-rich seeds or hemp seeds as superfoods. Arcadia Biosciences offers a variety of products aimed at improving agricultural production and nutrition. Some examples include NitroBoost, a fertilizer that reduces nitrogen loss and improves nutrient uptake in plants; GoodWheat flour, which contains more fiber and protein than conventional wheat flour and is suitable for baking and cooking; ArcaTech, a technology designed to facilitate crop cultivation in areas with limited access to water and nutrients; and hemp seeds, which are rich in essential fatty acids and proteins. In conclusion, Arcadia Biosciences is a company specializing in agricultural biotechnology. Through the development of plants that are resistant to diseases and environmental influences, the company aims to enable more sustainable agricultural production. Arcadia Biosciences has established itself as an important player in the agricultural industry through partnerships and product development. Arcadia Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Arcadia Biosciences's Market Capitalization

Arcadia Biosciences's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Arcadia Biosciences's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Arcadia Biosciences's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Arcadia Biosciences’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Arcadia Biosciences stock

What is the current Arcadia Biosciences market capitalization?

The current market capitalization of Arcadia Biosciences is 7.69 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Arcadia Biosciences.

How has the market capitalization of Arcadia Biosciences developed in recent years?

The market capitalization of Arcadia Biosciences has increased/decreased by 122.74% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Arcadia Biosciences?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Arcadia Biosciences?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Arcadia Biosciences have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Arcadia Biosciences pay?

Over the past 12 months, Arcadia Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arcadia Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Arcadia Biosciences?

The current dividend yield of Arcadia Biosciences is .

When does Arcadia Biosciences pay dividends?

Arcadia Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arcadia Biosciences?

Arcadia Biosciences paid dividends every year for the past 0 years.

What is the dividend of Arcadia Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arcadia Biosciences located?

Arcadia Biosciences is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Arcadia Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arcadia Biosciences from 12/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.

When did Arcadia Biosciences pay the last dividend?

The last dividend was paid out on 12/20/2024.

What was the dividend of Arcadia Biosciences in the year 2023?

In the year 2023, Arcadia Biosciences distributed 0 USD as dividends.

In which currency does Arcadia Biosciences pay out the dividend?

The dividends of Arcadia Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Arcadia Biosciences stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Arcadia Biosciences

Our stock analysis for Arcadia Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Arcadia Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.